Using Renin Activity to Guide Mineralocorticoid Receptor Antagonist Therapy in Patients with Low Renin and Hypertension

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) are often empirically used for patients with low-renin hypertension (LRH) or probable primary aldosteronism (PA) who decline surgery. However, the optimal approach to MRA therapy is unknown. Studies have shown that a rise in renin is an effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansur, Arian, Vaidya, Anand, Turchin, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345476/
https://www.ncbi.nlm.nih.gov/pubmed/37013957
http://dx.doi.org/10.1093/ajh/hpad032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345476/
https://www.ncbi.nlm.nih.gov/pubmed/37013957
http://dx.doi.org/10.1093/ajh/hpad032

Ejemplares similares